**ai-case-study**

## Overview and Origin

* *Name of company* * **Biofourmis**

* *When was the company incorporated?* * 2015 in Singapore 

* *Who are the founders of the company?* * Maulik Majmudar, Kuldeep Singh Rajput, and Mark Niu [^1]

* *How did the idea for the company (or project) come about?* * While completing his PhD in Singapore,company CEO, Kuldeep Singh Rajput dropped out to pursue AI technology [^1]
  
* *How is the company funded? How much funding have they received?* * As of 2022, Biofourmis has been funded $445 million through investors. Those investors include SoftBank Vision Fund 2, Openspace Ventures, Mass Mutual Ventures, Sequoia Capital and EDBI. In 2022, the company broke out of the unicorn status and into Series D investment with their partnership with General Atlantic [^2]

## Business Activities

* *What specific problem is the company or project trying to solve?* * The company is trying to bring hospital level care to patients in their own homes. This is implemented by combining AI programs and monitoring technology, in conjunction with FDA approved algorithms. The company is able to initiate virtual visits, along with personal care plans to prevent rehospitalization.In addition, Biofourmis helps people get involved in clinical trials by making user friendly tools and easy communication for participants. [^3] 

* *Who is the company's intended customer? Is there any information about the market size of this set of customers?* * The company is aiming to provide hospital level care to anyone who would like to seek medical attention reguardless of where they live. As per the company’s website, they have cared for 100,000 patients as of 2023 [^3]  

* *What solution does this company offer that their competitors do not or cannot offer? (What is the unfair advantage they utilize?)* * Biofourmis uses apps and easy to use biosensors to track a patient’s vital signs, as well as other biomarkers. This wearable technology provides data that is interpreted by an AI system to immediately assess a patient’s status. This AI platform takes the information and presents it to a medical team. This information is presented to medical professionals in a user-friendly format. It is also uploaded to a patient dashboard. This information can track acuity level and clinical goals for the patient. This AI tool can also adjust the level of care for the patient based on the changing conditions. [^3]

* *Which technologies are they currently using, and how are they implementing them? (This may take a little bit of sleuthing&mdash;you may want to search the company’s engineering blog or use sites like Stackshare to find this information.)* * Biofourmis uses several different technological aspects to build their AI system. The company uses an AI program called Biofourmis Biovitals. This is a system that monitors a patient’s physiological signs and compares it to their database. This information is then passed off to clinicians to make medical decisions. Along with the AI system, Biofourmis uses: BiovitalsHF, Rhythm Analytics, Biovitals Sentinel, Painfocus, Gaido and Biovitals Research. These are programs that the company uses in conjunction with the AI program. Those programs are monitoring software and cloud based software programs that can provide more data to the AI system.[^4] 

## Landscape

* *What field is the company in?* * Biotechnology

* *What have been the major trends and innovations of this field over the last 5&ndash;10 years?* * Over the past ten years there has been many new innovations in healthcare. As of 2022, the United Stated Food and Drug Administration (FDA) approved 91 medical devices with AI abilities [^5]. These devices range from cardiac arrhythmia tracking in Apple Watches and AI programed features in radiology devices to better highlight critical images. 
Advances in AI generated digital biomarkers have been used as an early detection for cancers and different cardiovascular diseases. AL has been used as a clinical decision support tool. This is very helpful to clinicians to be able to analyze historical data and determine a trend of the current date. Lastly, AI has been implemented in drug development. AI can use used to speed up the drug development process. For example, the medication * *Olumiant* * created by pharmaceutical company Eli Lilly used designed by AI [^5].


* What are the other major companies in this field?

## Results

* What has been the business impact of this company so far?

* What are some of the core metrics that companies in this field use to measure success? How is your company performing based on these metrics?

* How is your company performing relative to competitors in the same field?

## Recommendations

* If you were to advise the company, what products or services would you suggest they offer? (This could be something that a competitor offers, or use your imagination!)

* Why do you think that offering this product or service would benefit the company?

* What technologies would this additional product or service utilize?

* Why are these technologies appropriate for your solution?
* ** References**
* [^1] https://growjo.com/company/Biofourmis.
* [^2] https://www.biofourmis.com/news-insights/biofourmis-receives-significant-growth-investment-from-general-atlantic-to-surpass-unicorn-status#:~:text=To%20date%2C%20Biofourmis%20has%20raised,Ventures%2C%20Sequoia%20Capital%20and%20EDBI.
* [^3] https://www.biofourmis.com/platform
* [^4] https://faimglobal.org/biofourmis/
* [^5] https://insights.omnia-health.com/technology/top-5-ai-driven-medical-innovations-united-states.
*

